plasminogen activator inhibitors Latest Research Papers

2019 ◽

pp. 216-221

Author(s):

A. Estellés ◽

J. Gilabert ◽

J. Aznar ◽

F. España ◽

R. R. Schleef

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitors

Download Full-text

Rapid identification of urokinase plasminogen activator inhibitors from Traditional Chinese Medicines based on ultrafiltration, LC–MS and in silico docking

Journal of Pharmaceutical and Biomedical Analysis ◽

10.1016/j.jpba.2018.10.036 ◽

2019 ◽

Vol 164 ◽

pp. 241-248 ◽

Cited By ~ 6

Author(s):

Li Li ◽

Jing Kong ◽

Chun-hua Yao ◽

Xiu-feng Liu ◽

Ji-hua Liu

Keyword(s):

Plasminogen Activator ◽

In Silico ◽

Urokinase Plasminogen Activator ◽

Rapid Identification ◽

Traditional Chinese Medicines ◽

Plasminogen Activator Inhibitors ◽

Chinese Medicines ◽

In Silico Docking

Download Full-text

THE LEVEL OF PLASMINOGEN ACTIVATOR INHIBITORS 1 IN ASTHMA PATIENTS AND CORRELATION WITH LUNG FUNCTION AND DEGREE OF ASTHMA CONTROL

Respirology ◽

10.1111/resp.13420_11 ◽

2018 ◽

Vol 23 ◽

pp. 93-94

Keyword(s):

Lung Function ◽

Plasminogen Activator ◽

Asthma Control ◽

Plasminogen Activator Inhibitors ◽

Asthma Patients

Download Full-text

Is there a role for urokinase-type plasminogen activator inhibitors as maintenance therapy in patients with ovarian cancer?

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2016.06.002 ◽

2017 ◽

Vol 43 (2) ◽

pp. 252-257 ◽

Cited By ~ 7

Author(s):

P.A. van Dam ◽

A. Coelho ◽

C. Rolfo

Keyword(s):

Ovarian Cancer ◽

Maintenance Therapy ◽

Plasminogen Activator ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator

Download Full-text

Pathogenesis of Hereditary Angioedema with Normal C1 Inhibitor: Evidence for Abnormalities in Plasminogen Activator Inhibitors

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2014.12.1846 ◽

2015 ◽

Vol 135 (2) ◽

pp. AB277 ◽

Cited By ~ 1

Author(s):

Kusumam Joseph ◽

Baby G. Tholanikunnel ◽

Konrad Bork ◽

Allen P. Kaplan

Keyword(s):

Plasminogen Activator ◽

Hereditary Angioedema ◽

C1 Inhibitor ◽

Plasminogen Activator Inhibitors

Download Full-text

Is inhibition process better described with MD(QM/MM) simulations? The case of urokinase type plasminogen activator inhibitors

Journal of Computational Chemistry ◽

10.1002/jcc.21983 ◽

2012 ◽

Vol 33 (6) ◽

pp. 607-616 ◽

Cited By ~ 7

Author(s):

Florent Barbault ◽

François Maurel

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Inhibition Process

Download Full-text

Structure based drug design studies on urokinase plasminogen activator inhibitors using AutoDock

Proceedings of the Second International Conference on Computational Science, Engineering and Information Technology - CCSEIT '12 ◽

10.1145/2393216.2393301 ◽

2012 ◽

Author(s):

M. Naresh Babu ◽

R. Bhramaramba ◽

Allam Appa Rao

Keyword(s):

Drug Design ◽

Plasminogen Activator ◽

Urokinase Plasminogen Activator ◽

Plasminogen Activator Inhibitors ◽

Design Studies ◽

Structure Based Drug Design

Download Full-text

Molecular competition between plasminogen activator inhibitors type -1 and -2 for urokinase: Implications for cellular proteolysis and adhesion in cancer

Cancer Letters ◽

10.1016/j.canlet.2011.01.018 ◽

2011 ◽

Vol 303 (2) ◽

pp. 118-127 ◽

Cited By ~ 3

Author(s):

Sergei Lobov ◽

Marie Ranson

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitors

Download Full-text

ChemInform Abstract: Structure-Based Design, Synthesis and SAR of a Novel Series of Thiopheneamidine Urokinase Plasminogen Activator Inhibitors.

ChemInform ◽

10.1002/chin.200137136 ◽

2010 ◽

Vol 32 (37) ◽

pp. no-no

Author(s):

Nalin Subasinghe ◽

et al. et al.

Keyword(s):

Plasminogen Activator ◽

Urokinase Plasminogen Activator ◽

Plasminogen Activator Inhibitors ◽

Design Synthesis ◽

Abstract Structure

Download Full-text

ChemInform Abstract: 2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine Derivatives as Potent and Selective Urokinase-Type Plasminogen Activator Inhibitors.

ChemInform ◽

10.1002/chin.200248132 ◽

2010 ◽

Vol 33 (48) ◽

pp. no-no

Author(s):

Richard L. Mackman ◽

et al. et al.

Keyword(s):

Plasminogen Activator ◽

Plasminogen Activator Inhibitors ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator

Download Full-text

plasminogen activator inhibitors
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Type 1 and Type 2 Plasminogen Activator Inhibitors in Preeclampsia

Rapid identification of urokinase plasminogen activator inhibitors from Traditional Chinese Medicines based on ultrafiltration, LC–MS and in silico docking

THE LEVEL OF PLASMINOGEN ACTIVATOR INHIBITORS 1 IN ASTHMA PATIENTS AND CORRELATION WITH LUNG FUNCTION AND DEGREE OF ASTHMA CONTROL

Is there a role for urokinase-type plasminogen activator inhibitors as maintenance therapy in patients with ovarian cancer?

Pathogenesis of Hereditary Angioedema with Normal C1 Inhibitor: Evidence for Abnormalities in Plasminogen Activator Inhibitors

Is inhibition process better described with MD(QM/MM) simulations? The case of urokinase type plasminogen activator inhibitors

Structure based drug design studies on urokinase plasminogen activator inhibitors using AutoDock

Molecular competition between plasminogen activator inhibitors type -1 and -2 for urokinase: Implications for cellular proteolysis and adhesion in cancer

ChemInform Abstract: Structure-Based Design, Synthesis and SAR of a Novel Series of Thiopheneamidine Urokinase Plasminogen Activator Inhibitors.

ChemInform Abstract: 2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine Derivatives as Potent and Selective Urokinase-Type Plasminogen Activator Inhibitors.

Export Citation Format

plasminogen activator inhibitorsRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Type 1 and Type 2 Plasminogen Activator Inhibitors in Preeclampsia

Rapid identification of urokinase plasminogen activator inhibitors from Traditional Chinese Medicines based on ultrafiltration, LC–MS and in silico docking

THE LEVEL OF PLASMINOGEN ACTIVATOR INHIBITORS 1 IN ASTHMA PATIENTS AND CORRELATION WITH LUNG FUNCTION AND DEGREE OF ASTHMA CONTROL

Is there a role for urokinase-type plasminogen activator inhibitors as maintenance therapy in patients with ovarian cancer?

Pathogenesis of Hereditary Angioedema with Normal C1 Inhibitor: Evidence for Abnormalities in Plasminogen Activator Inhibitors

Is inhibition process better described with MD(QM/MM) simulations? The case of urokinase type plasminogen activator inhibitors

Structure based drug design studies on urokinase plasminogen activator inhibitors using AutoDock

Molecular competition between plasminogen activator inhibitors type -1 and -2 for urokinase: Implications for cellular proteolysis and adhesion in cancer

ChemInform Abstract: Structure-Based Design, Synthesis and SAR of a Novel Series of Thiopheneamidine Urokinase Plasminogen Activator Inhibitors.

ChemInform Abstract: 2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine Derivatives as Potent and Selective Urokinase-Type Plasminogen Activator Inhibitors.

plasminogen activator inhibitors
Recently Published Documents